Phase 2
Clinical trials for Phase 2 explained in plain language.
Never miss a new study
Get alerted when new Phase 2 trials appear
Sign up with your email to follow new studies for Phase 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat anal and rectal cancers
Disease control Not yet recruitingThis study tests a drug called sacituzumab tirumotecan in 20 people with advanced anal or rectal cancer that has spread or cannot be removed and has not responded to other treatments. The goal is to see if the drug can shrink tumors and how safe it is. Participants will receive t…
Matched conditions: PHASE 2
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new drug delay the need for lymphoma treatment?
Disease control Not yet recruitingThis phase 2 trial compares two approaches for people with untreated, low-tumor-burden follicular lymphoma: receiving the investigational drug epcoritamab or being closely monitored without treatment. The goal is to see if epcoritamab can extend the time before standard treatment…
Matched conditions: PHASE 2
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Blood tests may guide breast cancer treatment before surgery
Knowledge-focused Not yet recruitingThis phase 2 trial is testing whether blood tests and imaging scans can tell if chemotherapy is working in people with early-stage triple-negative breast cancer before they go to surgery. The study will enroll 200 participants who will receive a combination of chemotherapy drugs …
Matched conditions: PHASE 2
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC